Enanta Pharmaceuticals reported $20.32M in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US USD 14.81B 229M
Acorda Therapeutics ACOR:US USD 33.01M 1.96M
Amgen AMGN:US USD 6.65B 58M
Anika Therapeutics ANIK:US USD 40.26M 607K
Arrowhead Research ARWR:US USD 31.58M 837K
AstraZeneca AZN:LN USD 10.98B 211M
Biocryst Pharmaceuticals BCRX:US USD 75.83M 10.3M
Biogen BIIB:US USD 2.51B 80.6M
Bristol Myers Squibb BMY:US USD 11.22B 669M
Clovis Oncology CLVS:US USD 30.66M 1.48M
Enanta Pharmaceuticals ENTA:US USD 20.32M 838K
Gilead Sciences GILD:US USD 7.04B 782M
GlaxoSmithKline GSK:LN GBP 782.9B 90B
Halozyme Therapeutics HALO:US USD 208.98M 56.61M
Heron Therapeutics HRTX:US USD 26.56M 1.07M
Insmed INSM:US USD 67.73M 2.51M
Intercept Pharmaceuticals ICPT:US USD 77.59M 5.83M
Johnson & Johnson JNJ:US USD 23.79B 229M
Karyopharm Therapeutics KPTI:US USD 36.14M 3.53M
Ligand Pharmaceuticals LGND:US USD 62.51M 5.09M
Marinus Pharmaceuticals MRNS:US USD 2.34M 550K
Merk MRK:US USD 14.96B 366M
Neurocrine Biosciences NBIX:US USD 387.9M 9.7M
Novartis NOVN:VX USD 12.84B 243M
Novavax NVAX:US USD 734.58M 548.65M
Pfizer PFE:US USD 22.64B 5.1B
Ptc Therapeutics PTCT:US USD 217.13M 51.6M
Roche Holding ROG:VX CHF 32.3B 207M
Sarepta Therapeutics SRPT:US USD 230.27M 3.22M
Vertex Pharmaceuticals VRTX:US USD 2.33B 138.1M
YTE INCY:US USD 823.3M 88.09M